Clinical Trial

CANnabinoids in Pediatric ONCology

Name: CANnabinoids in Pediatric ONCology — clinical trial record (NCT05754840)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CAN-PONC

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

CANnabinoids in Pediatric ONCology is a randomized, double blind, adaptive clinical trial looking at the tolerability of cannabinoids in children with cancer across 3 Canadian children's hospitals.

Trial Details

NCT Number	NCT05754840
Lead Sponsor	University of Manitoba Collaborators: Canadian Cancer Society (CCS), Canadian Institutes of Health Research (CIHR)
Conditions	Childhood Cancer, Cancer
Enrollment	60 participants
Start Date	2025-07-18
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-11